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Triiodothyronine (T3) stimulates a 7-fold increase in
transcription of the acetyl-CoA carboxylase-␣ (ACC␣)
gene in chick embryo hepatocytes. Here, we characterized an ACC␣ T3 response element (ACC␣-T3RE) with
unique functional and protein binding properties.
ACC␣-T3RE activated transcription both in the absence
and presence of T3, with a greater activation observed
in the presence of T3. In nuclear extracts from hepatocytes incubated in the absence of T3, ACC␣-T3RE bound
protein complexes (complexes 1 and 2) containing the
liver X receptor (LXR) and the retinoid X receptor
(RXR). In nuclear extracts from hepatocytes incubated
in the presence of T3 for 24 h, ACC␣-T3RE bound a
different set of complexes. One complex contained LXR
and RXR (complex 3) and another contained the nuclear
T3 receptor (TR) and RXR (complex 4). Mutations of
ACC␣-T3RE that inhibited the binding of complexes 1
and 2 decreased transcriptional activation in the absence of T3, and mutations of ACC␣-T3RE that inhibited
the binding of complexes 3 and 4 decreased transcriptional activation in the presence of T3. The stimulation
of ACC␣ transcription caused by T3 was closely associated with changes in the binding of complexes 1– 4 to
ACC␣-T3RE. These data suggest that T3 regulates ACC␣
transcription by a novel mechanism involving changes
in the composition of nuclear receptor complexes bound
to ACC␣-T3RE. We propose that complexes containing
LXR/RXR ensure a basal level of ACC␣ expression for
the synthesis of structural lipids in cell membranes and
that complexes containing LXR/RXR and TR/RXR mediate the stimulation of ACC␣ expression caused by T3.

When the intake of dietary carbohydrate exceeds the immediate energy needs of the animal, excess carbohydrate is converted to triacylglycerols, which can be used for energy during
periods of fasting. One of the enzymes that plays a pivotal role
in mediating this response is acetyl-CoA carboxylase (ACC).1
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1
The abbreviations used are: ACC, acetyl-CoA carboxylase; bp, base
pair(s); COUP-TF, chicken ovalbumin upstream promoter transcription
factor; CAT, chloramphenicol acetyltransferase; DR4, half-sites arranged as direct repeats with a 4-bp spacer; LXR, liver X receptor; RXR,
retinoid X receptor; TK, thymidine kinase; T3, 3,5,3⬘-triiodothyronine;

ACC catalyzes the ATP-dependent carboxylation of acetyl-CoA
to malonyl-CoA, which is the donor of all but two () of the
carbon atoms for the synthesis of long-chain fatty acids. This
reaction is the pace-setting step of the fatty acid synthesis
pathway (1, 2). There are two ACC isoforms that are encoded
by distinct genes. ACC␣ (260 kDa) is the principal isoform
expressed in tissues that exhibit high rates of fatty acid synthesis such as liver, adipose tissue, and mammary gland. ACC␤
(280 kDa) is the major isoform observed in heart and skeletal
muscle, where it is thought to function primarily in the regulation of ␤-oxidation of fatty acids (3).
The concentration of ACC␣ in liver is subject to nutritional
and hormonal regulation. For example, in starved animals, the
concentration of hepatic ACC␣ is low; feeding a high carbohydrate, low fat diet stimulates an 8 –20-fold increase in the
amount of the enzyme (4 –7). The effects of nutritional manipulation on ACC␣ concentration are mediated primarily by
changes in the rate of transcription of the ACC␣ gene (8).
Diet-induced changes in ACC␣ transcription are mimicked in
primary cultures of chick embryo hepatocytes by manipulating
the concentration of hormones and nutrients in the culture
medium. The addition of 3,5,3⬘-triiodothyronine (T3) to the
culture medium stimulates a 7-fold increase in ACC␣ transcription (9). Interestingly, a relatively long time (24 h) is
required to achieve maximal rates of ACC␣ transcription after
the addition of T3, suggesting that the accumulation of a ratelimiting intermediate is involved in mediating this response.
The molecular mechanism by which T3 regulates ACC␣ transcription remains to be determined.
ACC␣ transcription is initiated from two promoters, resulting in mRNAs with heterogeneity in the 5⬘-untranslated region
(2). The more upstream promoter (promoter 1) flanks exon 1,
while the more downstream promoter (promoter 2) flanks exon
2. In livers of rats (10, 11) and chickens,2 the increase in total
ACC␣ mRNA abundance caused by the consumption of a high
carbohydrate, low fat diet is mediated by alterations in the
activities of promoter 1 and promoter 2, with the latter promoter playing a quantitatively greater role in mediating this
response. Alterations in promoter 2 activity are also primarily
responsible for the T3-induced stimulation in total ACC␣
mRNA abundance in chick embryo hepatocytes.2
Thyroid hormone action is initiated by the binding of T3 to
nuclear receptors. Nuclear T3 receptors (TRs) are members of a
superfamily of ligand-dependent transcription factors that include the receptors for steroid hormones, vitamin A derivaTR, nuclear T3 receptor; T3RE, T3 response element; CBP, CREBbinding protein.
2
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tives, vitamin D3, oxysterols, prostanoids, and a large family of
receptor-like proteins with unknown ligands (orphan receptors) (12, 13). TRs bind to DNA sequences denoted as T3 response elements (T3REs). A wide diversity of T3RE structures
have been reported in T3-responsive genes (14). In general,
T3REs consist of multiple copies of a hexameric sequence related to a consensus RGGWMA arranged as inverted repeats,
everted repeats, direct repeats, or extended single copies of the
hexamer. The nucleotide sequence of the hexameric half-sites
and flanking DNA and the spacing of the half-sites influence
the binding of TR and its interactions with other proteins
(15–18). Consequently, the structure of the T3RE is an important factor influencing the transcriptional activity of TR. TRs
can bind T3REs as monomers, homodimers, or heterodimers
with retinoid X receptor (RXR) (13, 14). TR/RXR heterodimers
are thought to be the principal species of TR bound to T3REs in
vivo, since this complex binds DNA with higher affinity and
modulates transcription more effectively than TR monomers
and TR homodimers (19 –21). In addition to TR and RXR, other
members of the nuclear hormone receptor family can regulate
transcription by binding to T3REs. For example, the ␣ and ␤
isoforms of the liver X receptor (LXR) heterodimerize with RXR
on an artificial T3RE composed of directly repeated half-sites
separated by a 4-bp spacer (22). Binding of LXR/RXR to this
T3RE causes a stimulation of transcription in the absence and
presence of ligands for LXR and RXR. Evidence that LXR/RXR
heterodimers modulate transcription through T3REs of native
genes is presently lacking.
TRs bound to T3REs exhibit two regulatory activities. In the
absence of T3, TRs repress transcription (23–26). The addition
of T3 causes a derepression of transcription and, in some instances, a further activation of transcription above that observed in the absence of TR (23). This dual regulatory activity
of TR arises, in part, from the ability of TR to recruit auxiliary
regulatory proteins referred to as corepressors and coactivators. In the absence of T3, TR binds to corepressors such as
silencing mediator for retinoic and thyroid hormone receptors
(27) and nuclear receptor corepressor (28). The presence of T3
causes the release of corepressors and the subsequent association of TR with coactivators (29, 30). Examples of coactivators
of TR include CREB-binding protein (CBP) (31, 32), steroid
receptor coactivator-1 (33), CBP-interacting protein (34, 35),
and p300/CBP associated factor (36). Corepressors and coactivators may mediate the transcriptional effects of TR by directly
interacting with the basal transcriptional machinery, by modulating interactions between TR and the basal transcriptional
machinery, and by modifying chromatin structure (13, 29, 37).
In the present report, we have investigated the mechanism
by which T3 regulates ACC␣ transcription in hepatocytes. A
strongly active T3RE in the 5⬘-flanking region of ACC␣ promoter 2 has been characterized. An interesting feature of this
ACC␣ T3RE that distinguishes it from T3REs of other T3responsive genes is that it activates transcription both in the
absence and presence of T3. In addition, this ACC␣ T3RE binds
multiple protein complexes in hepatic nuclear extracts, and
several of these complexes contain LXR/RXR heterodimers. We
also show that the T3-induced stimulation of ACC␣ transcription in hepatocytes is closely associated with dramatic changes
in the binding of LXR/RXR complexes and TR/RXR complexes
to the ACC␣ T3RE. From these data, we propose that T3
regulates ACC␣ transcription by a novel mechanism involving
changes in the binding of nuclear receptor complexes to a
T3RE.
EXPERIMENTAL PROCEDURES

Reporter Plasmids—An 18-kilobase pair ACC␣ genomic clone was
obtained by screening a  chicken genomic library (CLONTECH) with a
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polymerase chain reaction-generated DNA fragment extending from
⫺1500 to ⫺855 bp relative to the start site of transcription of chicken
ACC␣ promoter 2. The sequence of the primers used to generate the
⫺1500 to ⫺855 bp fragment was derived from the published ACC␣
promoter 2 sequence (38). ACC␣ DNA fragments used to construct
reporter plasmids were named by designating the 5⬘- and 3⬘-ends
of each fragment relative to the transcription start site. To construct p[ACC⫺4900/⫹274]CAT (HindIII/XhoI), p[ACC⫺2054/
⫹274]CAT (BamHI/XhoI), p[ACC⫺854/⫹274]CAT (PstI/XhoI),
p[ACC⫺391/⫹274]CAT (BsmI/XhoI), p[ACC⫺212/⫹274]CAT (MscI/
XhoI), p[ACC⫺136/⫹274]CAT (EagI/XhoI), and p[ACC⫺94/⫹274]CAT
(BstEII/XhoI), ACC␣ restriction fragments indicated in brackets were
inserted upstream of the chloramphenicol acetyltransferase (CAT) gene
in KSCAT (39). To construct p[ACC⫺108/⫹274]CAT, p[ACC⫺84/
⫹274]CAT, p[ACC⫺59/⫹274]CAT, p[ACC⫺41/⫹274]CAT, and
p[ACC⫺30/⫹274]CAT, ACC␣ fragments were amplified by polymerase
chain reaction and inserted upstream of the CAT gene in KSCAT.
pBLCAT2 (pTKCAT) was obtained from B. Luckow and G. Schutz
(German Cancer Research Center) (40). The cryptic activator protein-1
site located 5⬘ of the multiple cloning site in pBLCAT2 (41) was removed
by excising the NdeI/HindIII fragment from this plasmid followed by
religation. Fragments of the ACC␣ promoter/regulatory region were
inserted into SphI and SalI site 5⬘ of the herpes simplex virus thymidine kinase (TK) promoter in pTKCAT to form ACC/TKCAT constructs.
p[ACC⫺212/⫺82]TKCAT, p[ACC⫺171/⫺82]TKCAT, and p[ACC⫺212/
⫺108]TKCAT were constructed by first amplifying the indicated ACC␣
fragments using polymerase chain reaction and then subcloning them
into pTKCAT. p[ACC⫺136/⫺82]TKCAT, p[ACC⫺108/⫺82]TKCAT and
pTKCAT constructs containing mutations in the ⫺108 to ⫺82 fragment
were made by inserting annealed complementary synthetic oligonucleotides into pTKCAT. Structures of reporter plasmids were confirmed by
restriction enzyme mapping and nucleotide sequence analyses.
The cDNAs for human RXR␣ and chicken TR␣ were provided by R.
Evans (Salk Institute) and H. Samuels (New York University), respectively. D. Mangelsdorf (University of Texas Southwestern Medical Center) provided the cDNAs for human LXR␣ and LXR␤. Expression plasmids for RXR␣, TR␣, LXR␣, and LXR␤ were developed by subcloning
the cDNAs for these receptors into pSV-SPORT1 (Life Technologies,
Inc.).
Cell Culture and Transient Transfection—Primary cultures of chick
embryo hepatocytes were prepared as described previously (42) and
maintained in serum-free Waymouth’s medium MD705/1 containing 50
nM insulin (gift from Lilly) and corticosterone (1 M). Chick embryo
hepatocytes were incubated on 60-mm Petri dishes (Fisher) at 40 °C in
a humidified atmosphere of 5% CO2 and 95% air. Cells were transfected
6 h after plating, using 20 g of Lipofectin (Life Technologies), 2.5 g of
p[ACC⫺4900/⫹274]CAT or an equimolar amount of another reporter
plasmid, and pBluescript KS(⫹) to bring the total amount of transfected
DNA to 3.0 g/plate. At 18 h of incubation, the transfection medium was
replaced with fresh medium with or without T3 (1.5 M). At 66 h of
incubation, chick embryo hepatocytes were harvested, and cell extracts
were prepared as described by Baillie et al. (43). CAT activity (44) and
protein (45) were assayed by the indicated methods. All DNAs used in
transfection experiments were purified using the Qiagen endotoxin-free
kit.
Gel Mobility Shift Analysis—Twenty hours after being placed into
culture, chick embryo hepatocytes were incubated in Waymouth’s medium containing insulin and corticosterone with or without T3 for the
times indicated in the figure legends. Cells were harvested, and nuclear
extracts were prepared as described (46) except that the protease inhibitors, leupeptin (0.25 g/ml), benzamidine (10 mM), aprotinin (8
g/ml), and phenylmethylsulfonyl fluoride (0.5 mM) were added to the
extraction buffer at the indicated concentrations. Chicken TR␣, human
LXR␣, human LXR␤, and human RXR␣ were translated in vitro using
the TNT SP6 coupled reticulocyte lysate system (Promega). To assess
the relative efficiency of synthesis of the different receptor proteins,
incorporation of [35S]methionine into receptor proteins was measured
in parallel reactions. Double-stranded oligonucleotides were prepared
by combining equal amounts of the complementary single-stranded
DNA in a solution containing 10 mM Tris, pH 8.0, 1 mM EDTA followed
by heating to 90 °C for 2 min and then cooling to room temperature. The
annealed oligonucleotides were labeled by filling in overhanging 5⬘-ends
using the Klenow fragment of Escherichia coli DNA polymerase in the
presence of [␣-32P]dCTP and/or [␣-32P]dGTP. Binding reactions were
carried out in 20 l containing 18 mM HEPES, pH 7.9, 90 mM KCl, 0.18
mM EDTA, 0.45 mM dithiothreitol, 18% glycerol (v/v), 0.3 mg/ml bovine
serum albumin, and 2 g of poly(dI䡠dC). A typical reaction contained
20,000 cpm (0.1 ng) of labeled DNA and 10 g of nuclear extract or 2 l
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FIG. 1. Effects of deletions of the 5ⴕ-flanking region of ACC␣ promoter 2 on transcriptional activity in the absence and presence
of T3. Chick embryo hepatocytes were transiently transfected with p[ACC⫺4900/⫹274]CAT or equimolar amounts of other plasmids as described
under “Experimental Procedures.” After transfection, cells were treated with or without T3 for 48 h. Cells were then harvested, extracts were
prepared, and CAT assays were performed. Left, the constructs used in these experiments. The number at the left of each construct is the 5⬘-end
of ACC␣ DNA in nucleotides relative to the transcription initiation site of promoter 2. The 3⬘-end of each construct was ⫹274 bp. Right, CAT
activity of cells transfected with p[ACC⫺212/⫹274]CAT and treated with T3 was set at 100, and the other activities were adjusted proportionately.
The -fold stimulation by T3 was calculated by dividing the CAT activity for hepatocytes treated with T3 (⫹T3) by that for hepatocytes not treated
with T3 (⫺T3). The -fold responses were calculated for individual experiments and then averaged. The results are the means ⫾ S.E. of six
experiments. CAT activity of T3-treated hepatocytes transfected with p[ACC⫺212/⫹274]CAT was 320 ⫾ 42% conversion/h/mg of protein. a, the
-fold stimulation by T3 for p[ACC⫺108/⫹274]CAT is significantly higher than that of any other construct (p ⬍ 0.05).
of in vitro translated proteins. The reaction was carried out on ice for 60
min. DNA and DNA-protein complexes were resolved on 6% nondenaturing polyacrylamide gels at 4 °C in 0.5⫻ TBE (45 mM Tris, pH 8.3, 45
mM boric acid, 1 mM EDTA). Following electrophoresis, the gels were
dried and subject to storage phosphor autoradiography. For competition
experiments, unlabeled competitor DNA was mixed with radiolabeled
oligomer prior to the addition of nuclear extract. For antibody supershift experiments, nuclear extracts were incubated with antibodies for
30 min at 0 °C prior to the addition of the oligonucleotide probe. Monoclonal antibody that recognizes the ␣, ␤, and ␥ forms of RXR was
generously provided by P. Chambon (Strasbourg, France). Polyclonal
antibodies that recognized chicken ovalbumin upstream promoter-transcription factor I (N19), the ␣ and ␤ forms of chicken TR (FL-408), and
the ␣ and ␤ forms of LXR (C19) were purchased from Santa Cruz
Biotechnology, Inc. (Santa Cruz, CA). The synthetic oligonucleotides
that were used as probes or competitors in gel mobility shift assays are
listed in Figs. 3A and 6C.
RESULTS

Identification of Sequences That Confer T3 Regulation on
ACC␣ Promoter 2—Results from RNase protection analyses
indicated that the T3-induced stimulation of ACC␣ expression
in chick embryo hepatocytes is mediated primarily by changes
in the activity of promoter 2 of the ACC␣ gene.2 Transient
transfection experiments were performed to identify the
T3RE(s) mediating this regulation. In our initial experiments,
chick embryo hepatocytes were transfected with a series DNA
constructs containing 5⬘-deletions of ACC␣ promoter 2 linked
to the CAT gene. In hepatocytes transfected with the longest
construct, p[ACC⫺4900/⫹274]CAT, T3 caused a 4.2-fold increase in CAT activity (Fig. 1). Deletion of ACC-␣ sequences to
⫺2054, ⫺854, ⫺391, and ⫺212 bp had no effect on T3 responsiveness. Deletion of ACC␣ sequences from ⫺136 to ⫺108 bp
caused a 2.1-fold increase T3 responsiveness, suggesting that
the region between ⫺136 and ⫺108 bp contains a sequence that
inhibits T3 responsiveness. Deletion of ACC␣ sequences from
⫺108 to ⫺94 bp caused a marked decrease in promoter activity

in the absence and presence of T3. Because the extent of the
decrease in promoter activity was greater in cells incubated in
the presence of T3, T3 responsiveness was decreased by 83%.
Further deletion of ACC␣ sequence to a 5⬘-end points of ⫺84,
⫺59, and ⫺41 bp had no effect on residual T3 responsiveness
(about a 2-fold increase in CAT activity). Further deletion of
ACC␣ sequence to a 5⬘-end point of ⫺30 bp abolished promoter
activity in the absence and presence of T3 (data not shown).
These data suggest that the region between ⫺108 and ⫺94 bp
overlaps with a T3RE or an accessory element that augments
T3 responsiveness. In addition, another T3RE of weaker activity is located downstream of ⫺41 bp.
Analysis of 3⬘-deletions of ACC␣ DNA in the context of
p[ACC⫺94/⫹274]CAT indicated the presence of a T3RE or
T3RE accessory element between ⫹179 and ⫹151 bp.3 However, this T3 regulatory sequence was not detected in 3⬘-deletions containing the T3 regulatory sequence between ⫺212 and
⫺94 bp. This observation suggests that sequences upstream of
the transcription start site mediate most, if not all, of the T3
regulation of transcription initiated from ACC␣ promoter 2.
To obtain additional data indicating the presence of a T3RE
in the 5⬘-flanking region of ACC␣ promoter 2, chick embryo
hepatocytes were transfected with constructs containing ACC␣
DNA fragments linked to the minimal promoter of the herpes
simplex virus TK gene. The TK promoter alone was unresponsive to T3 in chick hepatocytes (Fig. 2). Appending an ACC␣
DNA fragment from ⫺212 to ⫺82 bp to the TK promoter caused
a 3.6-fold increase in T3 responsiveness. To further define the
location of the T3RE in the ⫺212 to ⫺82 bp fragment, a series
of deletions of p[ACC⫺212/⫺82]TKCAT were tested for their
ability to confer T3 responsiveness. Deletion of the 5⬘-end to
⫺171 bp caused a 36% increase in T3 responsiveness. Further
3
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FIG. 2. A strongly active T3RE is located between ⴚ108 and
ⴚ82 bp of the ACC␣ gene. Fragments of the ACC-␣ gene were linked
to the minimal TK promoter in pTKCAT. Hepatocytes were transiently
transfected with these constructs and treated with or without T3 as
described in the legend of Fig. 1 and under “Experimental Procedures.”
Left, constructs used in these experiments. Numbers indicate the 5⬘ and
3⬘ boundaries of ACC␣ DNA relative to the transcription initiation site
of promoter 2. Right, CAT activity in cells transfected with p[ACC⫺108/
⫺82]TKCAT and treated with T3 was set at 100, and the other activities were adjusted proportionately. The -fold stimulation by T3 was
calculated as described in the legend to Fig. 1. The results are the
means ⫾ S.E. of four experiments. The CAT activity of extracts from
T3-treated hepatocytes transfected with p[ACC⫺108/⫺82]TKCAT was
251 ⫾ 36% conversion/h/mg of protein. Significant differences between
means within a column (p ⬍ 0.05) are as follows. a, versus pTKCAT; b,
versus any other construct.

deletion to ⫺136 bp had no effect on T3 responsiveness. When
the 5⬘-end was deleted to ⫺108 bp, T3 responsiveness increased
from 5.7- to 10.2-fold. This observation is consistent with data
from 5⬘-deletion analysis in the context of p[ACC⫺4900/
⫹274]CAT (Fig. 1), suggesting the presence of a T3 inhibitory
element between ⫺136 and ⫺108 bp. When the 3⬘-end of the
⫺212 to ⫺82 fragment was deleted to ⫺108 bp, T3 responsiveness was abolished. Thus, the sequence between ⫺108 and ⫺82
bp contains a strongly active T3RE. Interestingly, this T3RE
confers T3 regulation by stimulating promoter activity both in
the absence and presence of T3, with a greater stimulation
observed in the presence of T3. These data support the results
from 5⬘-deletion analysis in the context of p[ACC⫺4900/
⫹274]CAT (Fig. 1) indicating the presence of a T3-dependent
and T3-independent enhancer element between ⫺108 and ⫺94
bp.
Analysis of the sequences between ⫺108 and ⫺82 bp revealed the presence of four hexameric half-sites (Fig. 3A). Two
of these half-sites (sites 2 and 3) conform perfectly to the
consensus T3RE half-site sequence, RGGWMA. The other two
half-sites (sites 1 and 4) are degenerate copies of the consensus
half-site sequence. Half-sites 1 and 3 form an imperfect direct
repeat with a 4-bp spacer (DR4) on the coding strand, and sites
2 and 4 form an imperfect DR4 on the noncoding strand. These
putative DR4 elements partially overlap with each other. Other
combinations of half-sites could form inverted or everted repeat
structures. To investigate which of the putative T3RE halfsites were involved in mediating T3 regulation, hepatocytes
were transfected with constructs that contained mutations of
individual half-sites in the context of p[ACC⫺108/⫺82]TKCAT.
Mutating the first 3 bp of half-site 1 (mut 1) had no effect on T3
responsiveness (Fig. 3B). In contrast, mutating the first 3 bp of
half-site 2 (mut 2) or half-site 4 (mut 4) abolished T3 responsiveness. This effect was mediated by a decrease in promoter
activity in the absence and presence of T3, with a greater effect

FIG. 3. Delineation of the sequences in the ⴚ108 to ⴚ82 bp
ACC␣ fragment that confer transcriptional activation in the
absence and presence of T3. A, native and mutant sequences of
putative half-sites located between ⫺108 and ⫺82 bp of the ACC␣ gene.
Underlined and overlined sequences in the native ⫺108 to ⫺82 bp
fragment are motifs that are similar to the consensus T3RE half-site
(top). The half-sites are numbered 1– 4. The arrows indicate the orientation of the half-sites. Half-sites 2 and 3 conform perfectly to the
consensus T3RE half-site sequence, whereas half-sites 1 and 4 are
degenerate copies of the consensus sequence. Mutations were introduced into individual half-sites in the context of p[ACC⫺108/⫺82]TKCAT. mut 1 to mut 4 refer to the number of the half-site that was
mutated in each construct. Mutated sequences are boxed. B, CAT activity of hepatocytes transfected with mutant reporter constructs.
Hepatocytes were transiently transfected as described in the legend of
Fig. 1 and under “Experimental Procedures.” After transfection, cells
were treated with or without T3 for 48 h. CAT activity in cells transfected with p[ACC⫺108/⫺82]TKCAT and treated with T3 was set at
100, and the other activities were adjusted proportionately. The results
are the means ⫾ S.E. of five experiments. The CAT activity of extracts
from T3-treated hepatocytes transfected with p[ACC⫺108/⫺82]TKCAT
was 238 ⫾ 26% conversion/h/mg of protein. Significant differences between means within a column (p ⬍ 0.05) are as follows. a, versus
p[ACC⫺108/⫺82]TKCAT treated without T3; b, versus p[ACC⫺108/
⫺82]TKCAT treated with T3; c, versus p[ACC⫺108/⫺82]TKCAT.

in the presence of T3. The first 3 bp of half-site 3 also comprise
part of the spacer separating half-sites 2 and 4. Mutating these
3 bp (mut 3) caused a 72% decrease in T3 responsiveness. This
effect was mediated by a decrease in promoter activity in the
presence of T3. These data demonstrate that T3 regulation
conferred by the ⫺108 to ⫺82 bp fragment is mediated by two
half-sites (sites 2 and 4) arranged as direct repeats on the
noncoding strand. Both of these half-sites are required for the
T3-dependent and T3-independent transcriptional activation
functions of this T3RE. The T3-dependent enhancer function is
also modulated by sequences in the spacer separating the two
half-sites.
Characterization of Nuclear Proteins That Bind the ACC␣
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FIG. 4. ACC␣-T3RE binds hepatic protein complexes containing LXR/RXR and TR/RXR. Gel mobility shift assays were performed
using nuclear extracts prepared from hepatocytes incubated with or
without T3 for 24 h. A double-stranded DNA fragment corresponding to
⫺108 to ⫺82 bp of the ACC␣ gene (ACC␣-T3RE) was labeled with
[␣-32P]dCTP using the Klenow fragment of E. coli DNA polymerase. The
radiolabeled probe was incubated with 10 g of nuclear protein as
described under “Experimental Procedures.” DNA and DNA-protein
complexes were resolved on 6% nondenaturing polyacrylamide gels. A,
nuclear extracts were incubated with antibodies against RXR and TR
prior to the addition of the probe. Competition analysis was performed
by mixing the labeled probe with a 20- and 100-fold molar excess of
unlabeled ACC␣-T3RE prior to the addition of nuclear extract. B, nuclear extracts were incubated with antibodies against COUP-TFI and
LXR prior to the addition of the probe. Positions of the specific proteinDNA complexes (arrows), nonspecific complexes (asterisk), and supershifted complexes (SS) are indicated. These results are representative
of four experiments employing independent preparations of nuclear
extract. NS, normal serum.

T3RE between ⫺108 and ⫺82 bp—Gel mobility shift analyses
were conducted to assess the binding of hepatic nuclear proteins to the T3RE between ⫺108 and ⫺82 bp. We will refer to
this T3RE as ACC␣-T3RE. Nuclear extracts were prepared
from hepatocytes incubated in the absence and presence of T3
for 24 h. Incubation of nuclear extracts with a 32P-labeled DNA
probe containing ACC␣-T3RE resulted in the formation of four
protein-DNA complexes designated 1– 4 in the order of increasing mobility (Fig. 4, A and B). The abundance of complex 1 and
complex 2 was markedly increased in nuclear extracts from
hepatocytes incubated in the absence of T3 relative to nuclear
extracts from hepatocytes incubated in the presence of T3.
Conversely, the abundance of complex 3 and complex 4 was
markedly elevated in nuclear extracts from hepatocytes incubated in the presence of T3 compared with nuclear extracts
from hepatocytes incubated in the absence of T3. A 100-fold
molar excess of unlabeled ACC␣-T3RE competed for the bind-

ing of complexes 1– 4, suggesting that the binding of these
protein-DNA complexes was specific (Fig. 4A).
Antibody supershift experiments were performed to identify
the proteins that interacted with ACC␣-T3RE. Antibodies directed against ␣, ␤, and ␥ isoforms of RXR completely disrupted
the formation of complex 3 and complex 4 (Fig. 4A). This result
was more readily observed in nuclear extracts from T3-treated
hepatocytes in which the abundance of complex 3 and complex
4 was elevated. RXR antibodies partially disrupted the formation of complex 1 and complex 2 in nuclear extracts from
hepatocytes incubated without T3. The disruption of complexes
1, 2, 3, and 4 by RXR antibodies was associated with the
appearance of a supershifted complex of high intensity. These
results suggest that most of the protein-DNA complexes that
interact with ACC␣-T3RE contain RXR or a protein highly
related to RXR. Antibodies directed against the ␣ and ␤ isoforms of TR completely disrupted the formation of complex 4
but had no effect on the formation of complexes 1–3. The
disruption of band 4 by TR antibody was associated with the
appearance of a supershifted complex. Thus, complex 4 appears
to contain TR/RXR heterodimers. Other proteins that can heterodimerize with RXR on DR4 elements include the ␣ and ␤
isoforms of LXR (22, 47). LXR␣ and LXR␤ are expressed abundantly in liver (47– 49). Preincubation of nuclear extracts with
antibodies directed against LXR␣ and LXR␤ partially disrupted the formation of complexes 1 and 2 in nuclear extracts
from hepatocytes incubated without T3 and disrupted the formation of complex 3 in nuclear extracts from hepatocytes incubated with T3 (Fig. 4B). Thus, complexes 1–3 appear to
contain LXR/RXR heterodimers. The orphan receptor, chicken
ovalbumin upstream promoter-transcription factor (COUPTF), also has been reported to bind T3REs (50, 51). Antibodies
against COUP-TFI had no effect on protein binding to
ACC␣-T3RE.
The ability of the ACC␣-T3RE to bind heterodimers containing LXR/RXR and TR/RXR was confirmed by gel mobility shift
experiments employing in vitro synthesized receptors. Incubation of in vitro translated LXR␣, LXR␤, RXR␣, or TR␣ with the
ACC␣-T3RE probe resulted in little or no DNA binding activity
(Fig. 5A). Inclusion of RXR␣ in the binding reactions with
LXR␣, LXR␤, and TR␣ stimulated the formation of high affinity protein-DNA complexes containing LXR␣/RXR␣, LXR␤/
RXR␣, and TR␣/RXR␣, respectively. Competition analyses indicated that the affinities of LXR␣/RXR␣, LXR␤/RXR␣, and
TR␣/RXR␣ for ACC␣-T3RE were similar (Fig. 5B).
Results from DNA binding analyses suggest that complex 1
and complex 2 mediate the enhancer activity of ACC␣-T3RE in
the absence of T3 and that complex 3 and complex 4 mediate
the increase in enhancer activity of ACC␣-T3RE caused by the
addition of T3. To obtain further data supporting this hypothesis, competition experiments were performed using unlabeled
DNA fragments containing native or mutant forms of ACC␣T3RE. These ACC␣-T3RE fragments were the same sequences
assayed in the transfection experiments described in Fig. 3.
Unlabeled ACC␣-T3RE, ACC␣-T3RE mut 1, and ACC␣-T3RE
mut 3 were more effective than ACC␣-T3RE mut 2 and ACC␣T3RE mut 4 in competing for the binding of complexes 1 and 2
in nuclear extracts from hepatocytes incubated in the absence
of T3 and complex 3 in nuclear extracts from hepatocytes
incubated in the presence of T3 (Fig. 6A). Thus, ACC␣-T3RE
mutants that abolished enhancer activity in the absence and
presence of T3 (i.e. ACC␣-T3RE mut 2 and ACC␣-T3RE mut 4)
bound proteins in complex 1, complex 2, and complex 3 with
reduced affinity. These findings are consistent with a role of
complexes 1 and 2 in mediating the enhancer activity of ACC␣T3RE in the absence of T3 and a role of complex 3 in mediating
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FIG. 5. ACC␣-T3RE binds LXR␣, LXR␤, and TR␣ as heterodimers with RXR␣. Gel mobility shift assays were performed as
described under “Experimental Procedures” using in vitro synthesized
nuclear receptors and 32P-labeled ACC␣-T3RE (⫺108 to ⫺82 bp) as the
probe. A, equimolar amounts of in vitro synthesized LXR␣, LXR␤, or
TR␣ were incubated with the radiolabeled probe in the absence or
presence of RXR␣ as indicated. In lanes 8 –10, receptor preparations
were incubated with antibodies against LXR or RXR prior to the addition of the probe. Positions of heterodimeric, homodimeric, monomeric,
and supershifted receptor complexes are indicated by arrows. Nonspecific complexes are indicated by an asterisk. B, the radiolabeled ACC␣T3RE probe was incubated with a 3-, 6-, 20-, and 100-fold molar excess
of unlabeled ACC␣-T3RE or ME-T3RE2 prior to the addition of in vitro
synthesized LXR␣/RXR␣, LXR␤/RXR␣, and TR␣/RXR␣. The sequence
of ME-T3RE2 is shown in Fig. 6C.

enhancer activity in the presence of T3. The competition profile
for complex 4 was different from that of complexes 1–3. In
nuclear extracts from hepatocytes incubated with T3, ACC␣T3RE and ACC␣-T3RE mut 1 were more effective than ACC␣T3RE mut 2 and ACC␣-T3RE mut 3 in competing for complex
4 binding activity. Thus, the inhibition of T3-induced transcriptional activity caused by ACC␣-T3RE mut 2 and ACC␣-T3RE
mut 3 is associated with a decrease in the binding of complex 4.
However, ACC␣-T3RE mut 1 and ACC␣-T3RE mut 4 exhibited
a similar ability to compete for the binding of complex 4 despite
the fact that these mutations caused markedly different effects
on T3-induced transcriptional activity. Thus, the elimination of
T3-dependent enhancer activity caused by mutation of the
more upstream half-site of the ACC␣-T3RE (i.e. ACC␣-T3RE
mut 4) is not associated with changes in the binding of TR/RXR.
Previous studies have shown that variations in the structure of
the upstream half-site of DR4-type T3REs can profoundly alter
T3-dependent enhancer activity without causing changes in
TR/RXR binding affinity (16). The mechanism mediating the
alteration in T3-dependent enhancer activity involves changes
in the conformation of TR/RXR heterodimers bound to DNA
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FIG. 6. The ability of native and mutant T3REs to compete for
the binding of hepatic nuclear proteins to ACC␣-T3RE. Gel mobility shift experiments were performed as described under “Experimental Procedures” using 32P-labeled ACC␣-T3RE as a probe and nuclear extracts prepared from hepatocytes incubated with or without T3
for 24 h. Nuclear extracts were incubated with the ACC␣-T3RE probe in
the presence of different concentrations of unlabeled competitor DNAs.
Each reaction contained 10 g of nuclear protein. DNA and DNAprotein complexes were resolved on 6% nondenaturing polyacrylamide
gels. Specific protein-DNA complexes are indicated by arrows. Bands 1
and 2 and bands 3 and 4 are the predominant protein-DNA complexes
observed with nuclear extracts from hepatocytes incubated in the absence of T3 and presence of T3, respectively. A, competition analysis
with native and mutant forms of ACC␣-T3RE. The sequences of the
ACC␣-T3RE competitors are shown in Fig. 3A. Unlabeled competitor
DNAs (6-, 20-, or 40-fold molar excess) were mixed with the radiolabeled
probe prior to the addition of nuclear extract. B, competition analysis
with the major T3RE of the chicken malic enzyme gene (ME-T3RE2).
Unlabeled ME-T3RE2 and ACC␣-T3RE (3-, 6-, 20-, or 100-fold molar
excess) were mixed with the radiolabeled probe prior to the addition of
nuclear extract. C, comparison of the sequence of ME-T3RE2 with that
of ACC␣-T3RE. The arrows indicate the position and orientation of the
half-sites. ⫺T3 NE, nuclear extracts from hepatocytes treated without
T3; ⫹T3 NE, nuclear extracts from hepatocytes treated with T3. These
data are representative of four experiments employing independent
preparations of nuclear extract.

(52). This mechanism may explain the effect of ACC␣-T3RE
mut 4 on T3-dependent enhancer activity.
The major T3RE mediating the T3 regulation of the chicken
malic enzyme gene is a DR4-type element located between
⫺3883 and ⫺3858 bp and is referred to as ME-T3RE2 (39, 53).
In contrast to the transcriptional enhancer function of ACC␣T3RE in chick embryo hepatocytes incubated in the absence of
T3 (Figs. 1, 2, and 3B), ME-T3RE2 functions as a strong repressor of transcription in chick embryo hepatocytes incubated
under the same experimental conditions (53). Both ACC␣T3RE and ME-T3RE2 activate transcription in hepatocytes
incubated in the presence of T3. The different activities of
ACC␣-T3RE and ME-T3RE2 in hepatocytes incubated in the
absence of T3 may be due to differences in the binding affinities
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of these T3REs for complexes 1 and 2. To investigate this
possibility, we examined the ability of different concentrations
of unlabeled ME-T3RE2 to compete for protein binding to 32Plabeled ACC␣-T3RE. A 100-fold molar excess of ME-T3RE2
was not effective in competing for the binding of complex 1 and
complex 2 in nuclear extracts from hepatocytes incubated without T3 (Fig. 6B). The inability of ME-T3RE2 to bind the proteins in complex 1 and complex 2 is consistent with these
complexes functioning as activators of transcription in the absence of T3. To investigate whether common factors were involved in mediating the T3-dependent enhancer activities of
ACC␣-T3RE and ME-T3RE2, competition experiments were
performed using nuclear extracts from hepatocytes incubated
in the presence of T3. ME-T3RE2 was effective in competing for
the binding of complex 4 but was not effective in competing for
complex 3. This observation suggests that the proteins comprising complex 4 (i.e. TR/RXR heterodimers) mediate the T3dependent enhancer activities of both ACC␣-T3RE and MET3RE2. The inability of ME-T3RE2 to bind complexes
containing LXR/RXR heterodimers (i.e. complexes 1–3) was
confirmed by experiments demonstrating that ME-T3RE2 was
not effective in competing for binding of in vitro synthesized
LXR␣/RXR␣ (Fig. 5B).
Previous work from our laboratory has shown that in hepatocytes incubated in the presence of insulin, the stimulation of
ACC␣ transcription by T3 occurs in two phases (Fig. 7A) (9).
Incubating hepatocytes with T3 for 1 h causes a small increase
(1.9-fold) in ACC␣ transcription. Between 1 and 5 h of T3
treatment, there is no change in the rate of ACC␣ transcription. After 5 h of T3 treatment, the rate of ACC␣ transcription
increases again. A maximal rate of ACC␣ transcription is
reached after 24 h of T3 treatment and is about 7 times the
transcription rate observed before the addition of T3. To investigate the temporal relationship between ACC␣ transcription
and the binding of nuclear proteins to ACC␣-T3RE, the time
course of the effects of T3 on protein binding to ACC␣-T3RE
was determined. Nuclear extracts from hepatocytes incubated
with or without T3 for different times were subjected to gel
mobility shift analysis using ACC␣-T3RE as a probe. As observed earlier in Fig. 4, ACC␣-T3RE primarily bound complexes 1 and 2 in nuclear extracts from hepatocytes incubated
in the absence of T3 (Fig. 7B). Incubation of hepatocytes with
T3 for 1 and 5 h had no effect on the pattern of protein binding
to ACC␣-T3RE. Between 5 and 24 h of T3 treatment, the
binding of complexes 3 and 4 increased and the binding of
complexes 1 and 2 decreased. The pattern of protein binding to
ACC␣-T3RE at 48 h of T3 treatment was similar to that at 24 h
of T3 treatment (data not shown). Thus, T3-induced alterations
in protein binding to ACC␣-T3RE are closely correlated with
the large increase in ACC␣ transcription between 5 and 24 h of
hormone treatment. This observation provides further evidence that alterations in the binding of complexes 1– 4 are
involved mediating the T3-induced increase in ACC␣
transcription.
Effects of Expression of Exogenous LXR, RXR, and TR on
ACC␣-T3RE Function—Results of DNA binding analyses
(Figs. 4 and 5) suggest that complexes containing LXR/RXR
heterodimers mediate the transcriptional enhancer activity of
ACC␣-T3RE in hepatocytes incubated in the absence of T3. To
obtain additional data supporting this hypothesis, we determined the effects of expression of exogenous LXR␣, LXR␤,
RXR␣, LXR␣ plus RXR␣, or LXR␤ plus RXR␣ on transcription
directed by the ACC␣-T3RE. Chick embryo hepatocytes were
transiently transfected with p[ACC⫺108/⫺82]TKCAT and expression plasmids containing or lacking the genes for LXR␣,
LXR␤, or RXR␣. Overexpression of RXR␣ alone had no effect on

FIG. 7. Time course for T3-induced changes in the binding of
hepatic nuclear proteins to ACC␣-T3RE. A, previously published
data for the time course of the T3-induced increase in ACC␣ transcription. Nuclear run-on assays were performed using nuclei isolated from
hepatocytes incubated in the absence or presence of T3 for the indicated
time periods. These data were taken from Hillgartner et al. (9). B, time
course for T3-induced changes in protein binding to ACC␣-T3RE. Gel
mobility shift assays were performed using nuclear extracts prepared
from hepatocytes incubated in the absence or presence of T3 for the
indicated time periods. Nuclear extracts (10 g of protein) were incubated with 32P-labeled ACC␣-T3RE as described under “Experimental
Procedures.” DNA and DNA-protein complexes were resolved on 6%
nondenaturing polyacrylamide gels. Specific protein-DNA complexes
are indicated by arrows. Nonspecific complexes are indicated by an
asterisk. These data are representative of four experiments employing
independent preparations of nuclear extract.

p[ACC⫺108/⫺82]TKCAT activity in hepatocytes incubated in
the absence or presence of T3 (Fig. 8). In contrast, overexpression of LXR␣ or LXR␤ alone or in combination with RXR␣
stimulated a 2.5–3-fold increase in p[ACC⫺108/⫺82]TKCAT
activity in the absence of T3; overexpression of these receptors
had no effect on p[ACC⫺108/⫺82]TKCAT activity in the presence of T3. When hepatocytes were transfected with a reporter
plasmid lacking the ACC␣-T3RE (pTKCAT), overexpression of
LXR␣, LXR␤, RXR␣, LXR␣ plus RXR␣, or LXR␤ plus RXR␣
had no effect on promoter activity in the absence or presence of
T3 (data not shown). These data are consistent with a role of
LXR/RXR heterodimers in mediating the enhancer activity of
ACC␣-T3RE in the absence of T3.
We also investigated the effects of overexpression of TR␣ on
p[ACC⫺108/⫺82]TKCAT activity in chick embryo hepatocytes.
In contrast to the results for LXR␣ and LXR␤, overexpression
of TR␣ and TR␣ plus RXR␣ caused an 88 and 91% decrease in
p[ACC⫺108/⫺82]TKCAT activity, respectively, in hepatocytes
incubated in the absence of T3; overexpression of these receptors had no effect on p[ACC⫺108/⫺82]TKCAT activity in hepatocytes incubated in the presence of T3 (Fig. 8). These data
provide further evidence that TR/RXR heterodimers are not
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FIG. 8. Effects of expression of exogenous LXR␣, LXR␤, RXR␣,
and TR␣ on transcription directed by ACC␣-T3RE. Chick embryo
hepatocytes were transiently transfected with p[ACC⫺108/⫺82]TKCAT (1 g/plate) and pSV-SPORT1-based expression plasmids (0.1
g/plate) expressing the genes for LXR␣, LXR␤, RXR␣, and TR␣. In
transfections containing two receptor expression plasmids, 0.1 g of
each plasmid was transfected per plate. Empty expression plasmid
(pSV-SPORT1) was added to bring the total amount of expression
plasmid transfected per plate to 0.2 g. Control transfections contained
0.2 g/plate of empty expression plasmid. After transfection, cells were
treated with or without T3 for 48 h. CAT activity in cells transfected
with p[ACC⫺108/⫺82]TKCAT plus empty expression plasmid (control)
and treated with T3 was set at 100, and the other activities were
adjusted proportionately. The results are the means ⫾ S.E. of three
experiments. The CAT activity of extracts from T3-treated hepatocytes
transfected with p[ACC⫺108/⫺82]TKCAT and empty expression plasmid was 214 ⫾ 33% conversion/h/mg of protein. *, mean is significantly
different (p ⬍ 0.05) from that of cells transfected with p[ACC⫺108/
⫺82]TKCAT plus empty expression plasmid (control) and incubated
without T3.

involved in mediating the enhancer activity of ACC␣-T3RE in
the absence of T3.
DISCUSSION

Previous studies analyzing the functional properties of TRs
in vivo and in vitro have shown that the unliganded form of TR
represses transcription and that the binding of T3 to TR reverses this effect and, in some instances, stimulates transcription above that observed in the absence of TR (13, 23–26).
Accordingly, several native and artificial T3REs have been
shown to confer T3 responsiveness by repressing transcription
in the absence of T3 and activating transcription in the presence of T3 (53–56). In the present report, we have identified a
T3RE (ACC␣-T3RE) with different functional properties.
ACC␣-T3RE confers T3 regulation on ACC␣ promoter 2 in
chick embryo hepatocytes by stimulating transcription both in
the absence and presence of T3, with a greater stimulation
observed in the presence of T3. These transcriptional effects of
ACC␣-T3RE were observed in the presence of endogenous cellular proteins; overexpression of TR or other proteins was not
required to elicit a T3 response from transfected genes in chick
embryo hepatocytes. To our knowledge, this is the first report
describing a T3RE that functions as a T3-independent enhancer of transcription during physiological conditions.
Results from DNA binding (Figs. 4, 5, and 7), competition
(Fig. 6), and transient transfection (Fig. 8) analyses suggest
that the T3-independent enhancer activity of ACC␣-T3RE is
mediated by protein complexes containing LXR/RXR heterodimers (complexes 1 and 2) and that the increase in ACC␣T3RE enhancer activity caused by T3 treatment is mediated by
protein complexes containing TR/RXR heterodimers (complex
4) and LXR/RXR heterodimers (complex 3). This is the first
time that LXR/RXR heterodimers have been shown to play a
role in mediating the transcriptional activity of a physiologically relevant T3RE. The different LXR/RXR complexes that
bind ACC␣-T3RE in hepatocytes may contain LXR and/or RXR
of different sizes. The binding of coregulatory proteins to LXR/
RXR heterodimers may also account for the different LXR/RXR
complexes.
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LXRs were initially identified as orphan receptors by screening libraries for homologues of nuclear hormone receptors and
were subsequently shown to be bound and activated by naturally occurring oxysterols at physiological concentrations (47–
49, 57). LXR/RXR binding sites have been identified in the
genes for cholesterol 7␣-hydroxylase (58), cholesterol ester
transfer protein (59), and ABC1 (60, 61). These binding sites
resemble DR4 elements and confer transcriptional activation
in both the absence and presence of oxysterols, with a greater
activation observed in the presence of oxysterols. There are no
reports that the LXR/RXR binding sites in the genes for cholesterol 7␣-hydroxylase, cholesterol ester transfer protein, and
ABC1 confer T3 regulation of transcription. LXR has been
proposed to play a key role in the regulation of cholesterol
excretion in animals, as cholesterol 7␣-hydroxylase, cholesterol
ester transfer protein, and ABC1 are proteins involved in the
regulation of reverse cholesterol transport. Conclusive evidence
supporting a role of LXR␣ in the regulation of cholesterol
catabolism has come from the characterization of the LXR␣
knockout mice. LXR␣ ablation causes an accumulation of cholesterol esters in liver as a result of an inability of cholesterol
7␣-hydroxylase to be induced by dietary cholesterol (62). Studies with LXR␣ knockout mice also indicate that LXR␣ regulates
expression of genes involved in fatty acid metabolism. For
example, ablation of LXR␣ in mice causes a marked decrease in
the expression of fatty acid synthase and stearoyl-CoA desaturase in liver (62); the molecular mechanisms mediating these
effects are not known. The results of the present study demonstrating that LXR binds and activates the ACC␣ gene in hepatocytes provide additional support for a role of LXR in the
regulation of lipogenic enzyme expression.
Previous work from our laboratory has shown that a relatively long time (24 h) is required to reach maximal rates of
ACC␣ transcription after the addition of T3 and that most of
the increase in transcription occurs between 5 and 24 h of
hormone treatment (9). Comparison of the time course of T3induced changes in ACC␣ transcription with the time course of
T3-induced changes in ACC␣-T3RE binding activity indicates
that the increase in ACC␣ transcription between 5 and 24 h of
T3 treatment is closely associated with an increase in the
binding of complexes 3 and 4 and a decrease in the binding of
complexes 1 and 2 (Fig. 7). This observation suggests that
regulation of ACC␣ transcription by T3 is mediated by novel
mechanism involving alterations in the composition of nuclear
receptor complexes bound to ACC␣-T3RE. We propose the following model for the regulation of ACC␣ transcription by T3.
The small increase in transcription observed within 1 h of T3
addition is mediated by a ligand-induced stimulation of the
derepression/activation function of TR in complex 4. This initial stimulation of ACC␣ transcription by T3 is limited by the
low binding activity of complex 4 to the ACC␣-T3RE relative to
that of complex 1 and complex 2. The large increase in ACC␣
transcription between 5 and 24 h of T3 treatment is mediated
by the increase in binding of complex 3 and complex 4 and the
decrease in binding of complex 1 and complex 2. In this model,
complex 3 and T3-bound complex 4 are more potent activators
of transcription than complex 1 and complex 2. The relatively
long time (⬎5 h) required to detect T3-induced changes in
protein binding to ACC␣-T3RE suggests that alterations in the
synthesis of a regulatory protein are involved in mediating this
effect. While the identity of this regulatory protein is not
known, it does not appear to be TR or RXR, since expression of
TR␣, TR␤, RXR␣, and RXR␥ is not affected by T3 treatment in
chick embryo hepatocytes (63). Data from Western blot analyses indicate that the concentration of LXR␣ and LXR␤ in chick
embryo hepatocytes is also not affected by T3 treatment.3 We
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speculate that T3 regulates the expression of nuclear receptor
accessory proteins that, in turn, modulate protein binding to
ACC␣-T3RE. Such accessory proteins may regulate ACC␣T3RE binding activity by physically interacting with complexes
1, 2, 3, and/or 4 or by altering the phosphorylation state of
these protein complexes.
In contrast to ACC␣-T3RE, the major T3RE of the malic
enzyme gene, ME-T3RE2, functions as a potent repressor of
transcription in the absence of T3 (53). If complex 1 and complex 2 mediate the T3-independent enhancer activity of ACC␣T3RE in hepatocytes, then what are the factors that mediate
the T3-independent repressor activity of ME-T3RE2? In previous work, we have shown that ME-T3RE2 binds to four complexes in nuclear extracts from chick embryo hepatocytes incubated without T3 (63). In contrast to the protein binding profile
for ACC␣-T3RE, all four complexes that interact with MET3RE2 contain TR, and three of the four complexes contain
RXR. Thus, the T3-independent repressor activity of MET3RE2 is likely to be mediated by one or more complexes
containing unliganded TR. This supposition is consistent with
previous studies demonstrating that unliganded TR functions
as a repressor of transcription (26). Interestingly, in chick
embryo hepatocytes incubated in the absence of T3, the transcription rate of the malic enzyme gene as determined by
nuclear run-on analysis is 30% of that observed for the ACC␣
gene.4 This difference in transcription rate between malic enzyme and ACC␣ is likely to be mediated, at least in part, by the
contrasting T3-independent activities of ME-T3RE2 and
ACC␣-T3RE.
In theory, the ability of a T3RE to bind TR and repress
transcription in the absence of T3 serves to amplify the activating effects of T3 on transcription. Indeed, the robust T3induced stimulation of transcription conferred by ME-T3RE2
in chick embryo hepatocytes (⬎270-fold) (53) is consistent with
this hypothesis. What is the physiological significance of the
enhancer activity of ACC␣-T3RE in the absence T3? In addition
to its role in energy homeostasis, ACC␣ is required for the
synthesis of structural lipids in cell membranes. Consequently,
a basal level of ACC␣ expression is observed under conditions
when the enzyme is not induced by hormonal and nutritional
factors. We propose that the ACC␣-T3RE also has a dual physiological role. In addition to mediating the hormonal regulation
of ACC␣ expression, ACC␣-T3RE ensures a basal level of ACC␣
expression for obligatory cellular processes. The latter function
of the ACC␣-T3RE is mediated by the binding of LXR/RXR
complexes. ACC␣-T3RE may also contribute to the basal expression of ACC␣ in extrahepatic tissues, as LXR␤ is expressed
in a wide variety of tissues (48, 49).
In summary, we have characterized a T3RE in the ACC␣
gene with unique functional and protein binding properties. In
addition, we have developed data suggesting that the delayed
actions of T3 on ACC␣ transcription are mediated by a novel
mechanism involving alterations in the composition of nuclear
receptor complexes bound to the ACC␣-T3RE. The observation
that the ACC␣-T3RE co-localizes with a prominent DNase Ihypersensitive site in chromatin from livers of intact chickens
supports a role for this cis-acting sequence in mediating the
regulation of ACC␣ transcription in vivo.2 Future experimentation will be directed toward defining the mechanism by which
T3 modulates the binding of nuclear receptor complexes to the
ACC␣-T3RE in hepatocytes.
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